Total Payments
$106,680
2024 Payments
$6,153
Companies
14
Transactions
144
Payment Breakdown by Category
Other$52,750 (49.4%)
Consulting$35,365 (33.2%)
Travel$14,162 (13.3%)
Food & Beverage$3,975 (3.7%)
Education$428.55 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $35,365 | 16 | 33.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $29,090 | 11 | 27.3% |
| Honoraria | $23,660 | 6 | 22.2% |
| Travel and Lodging | $14,162 | 27 | 13.3% |
| Food and Beverage | $3,975 | 69 | 3.7% |
| Education | $428.55 | 15 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| CSL Behring | $57,685 | 51 | $0 (2023) |
| Grifols USA, LLC | $27,685 | 51 | $0 (2024) |
| GlaxoSmithKline, LLC. | $4,550 | 1 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $4,460 | 5 | $0 (2024) |
| Grifols Canada Ltd. | $3,802 | 5 | $0 (2021) |
| Shire North American Group Inc | $3,275 | 6 | $0 (2018) |
| AstraZeneca AB | $3,150 | 4 | $0 (2020) |
| VERTEX PHARMACEUTICALS INCORPORATED | $1,334 | 7 | $0 (2019) |
| Grifols Shared Services North America, Inc. | $354.81 | 7 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $135.95 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $6,153 | 8 | GlaxoSmithKline, LLC. ($4,550) |
| 2023 | $7,966 | 6 | CSL Behring ($3,303) |
| 2022 | $881.66 | 4 | Takeda Pharmaceuticals U.S.A., Inc. ($586.22) |
| 2021 | $9,249 | 5 | CSL Behring ($3,533) |
| 2020 | $27,904 | 12 | CSL Behring ($18,474) |
| 2019 | $26,767 | 33 | CSL Behring ($18,958) |
| 2018 | $19,037 | 48 | CSL Behring ($13,418) |
| 2017 | $8,723 | 28 | Grifols USA, LLC ($4,998) |
All Payment Transactions
144 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Grifols USA, LLC | — | Consulting Fee | Cash or cash equivalent | $1,425.00 | General |
| 11/25/2024 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $4,550.00 | General |
| 10/06/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | In-kind items and services | $40.34 | General |
| 09/12/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: Hyperkalemia | ||||||
| 08/20/2024 | Grifols Shared Services North America, Inc. | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $34.56 | General |
| Category: Pulmonology | ||||||
| 05/30/2024 | Vifor Pharma, Inc. | Zemaira (Drug) | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 05/19/2024 | Grifols Shared Services North America, Inc. | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $46.29 | General |
| Category: Pulmonology | ||||||
| 04/08/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: Pulmonology | ||||||
| 12/05/2023 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Consulting Fee | Cash or cash equivalent | $2,460.00 | General |
| Category: Pulmonology | ||||||
| 12/05/2023 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $3.28 | General |
| Category: IMMUNOLOGY | ||||||
| 11/03/2023 | Grifols Shared Services North America, Inc. | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $27.68 | General |
| Category: Pulmonology | ||||||
| 08/12/2023 | CSL Behring | Zemaira (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $3,302.55 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 04/07/2023 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Consulting Fee | Cash or cash equivalent | $2,150.00 | General |
| Category: IMMUNOLOGY | ||||||
| 03/14/2023 | Grifols Shared Services North America, Inc. | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: Pulmonology | ||||||
| 12/18/2022 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Travel and Lodging | In-kind items and services | $586.22 | General |
| Category: IMMUNOLOGY | ||||||
| 05/17/2022 | Grifols Shared Services North America, Inc. | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $81.39 | General |
| Category: Pulmonology | ||||||
| 05/15/2022 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $112.13 | General |
| Category: Pulmonology | ||||||
| 02/03/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $101.92 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/15/2021 | Grifols Canada Ltd. | — | Consulting Fee | Cash or cash equivalent | $1,200.00 | General |
| 11/16/2021 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $116.71 | General |
| Category: Pulmonology | ||||||
| 09/30/2021 | Grifols Canada Ltd. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,200.00 | General |
| 09/13/2021 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Consulting Fee | Cash or cash equivalent | $3,200.00 | General |
| Category: Pulmonology | ||||||
| 04/28/2021 | CSL Behring | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $3,532.75 | General |
| 12/11/2020 | AstraZeneca AB | — | Consulting Fee | Cash or cash equivalent | $450.00 | General |
| 11/04/2020 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| Category: Pulmonology | ||||||
About Robert Sandhaus, M.D., PH.D
Robert Sandhaus, M.D., PH.D is a Pulmonary Disease healthcare provider based in Denver, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1093884652.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Robert Sandhaus, M.D., PH.D has received a total of $106,680 in payments from pharmaceutical and medical device companies, with $6,153 received in 2024. These payments were reported across 144 transactions from 14 companies. The most common payment nature is "Consulting Fee" ($35,365).
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Pulmonary Disease
- Location Denver, CO
- Active Since 11/07/2006
- Last Updated 03/17/2021
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1093884652
Products in Payments
- Zemaira (Biological) $47,594
- Prolastin-C Liquid (Biological) $17,453
- Prolastin-C (Biological) $10,502
- GLASSIA (Biological) $7,637
- DUPIXENT (Biological) $101.92
- KALYDECO (Drug) $98.99
- OCTAGAM (Biological) $89.65
- UTIBRON (Drug) $46.47
- Veltassa (Drug) $21.51
- Zemaira (Drug) $18.85
- BEVESPI AEROSPHERE (Drug) $16.98
- Alphanate (Biological) $13.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Denver
Dr. Ronald Balkissoon, Md, MD
Pulmonary Disease — Payments: $1.5M
Pulmonary Disease $1.5M
Kevin Brown, Md, MD
Pulmonary Disease — Payments: $333,953
Pulmonary Disease $333,953
David Griffith, Md, MD
Pulmonary Disease — Payments: $287,061
Pulmonary Disease $287,061
Barry Make, Md, MD
Pulmonary Disease — Payments: $244,103
Pulmonary Disease $244,103
Dr. David Beuther, Md, MD
Pulmonary Disease — Payments: $155,207
Pulmonary Disease $155,207
Evans Fernandezperez, M.d, M.D
Pulmonary Disease — Payments: $149,782
Pulmonary Disease $149,782